Randox Biochip Array Technology

Randox Biochip Array Technology offers a diagnostic-grade testing solution for the detection of drugs in oral fluids with reliable and reproducible results.

The biochip arrays offer a one-shot multiplex assay, detecting up to 97 drugs and drug metabolites from an undivided oral fluid sample. Matrix dedicated kits ensure leading assay performance and high specificity, even at lower drug concentrations.

Randox biochip arrays meet the limit of detection requirements for both the European Workplace Drug Testing Society guidelines for oral fluid testing (2010) and the Australian and New Zealand procedures for specimen collection and the detection and quantification of drugs in oral fluid AS 4760-2006 (2006).

The efficient biochip arrays also provide a rapid turnaround time, which is advantageous for on-site workplace drug testing. In comparison, a four-plate automated ELISA system would require thirteen times longer to process the same results.

Randox recently launched a point of collection biochip analyser; the Evidence MultiStat which processes multiple results in less than 20 min. The Biochip platform is multi-matrix, therefore a number of sample types including oral fluid, whole blood, urine and post-mortem tissue can be run on the system. The Randox line of Evidence immunoassay analysers generate quality control data automatically with every run, ensuring that each test has been carried out successfully.